[1]CurrentPatentAssignee:LIGANDPHARMACEUTICALSINC;MERCK&COINC-WO2004/33440,2004,A1Locationinpatent:Page298-299
[2]CurrentPatentAssignee:LIGANDPHARMACEUTICALSINC;MERCK&COINC-US2004/147559,2004,A1Locationinpatent:Page163
[3]CurrentPatentAssignee:LIGANDPHARMACEUTICALSINC;MERCK&COINC-US2004/106794,2004,A1Locationinpatent:Page163
[4]Kushneretal.[JournalofOrganicChemistry,1948,vol.13,p.144,149]
[5]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2007/117796,2007,A1Locationinpatent:Page/Pagecolumn14
[1]Ram;Wise;Wotring;McCall;Townsend[JournalofMedicinalChemistry,1992,vol.35,#3,p.539-547]
[1]Stürzebecher,Jörg;Prasa,Dagmar;Hauptmann,Jörg;Vieweg,Helmut;Wikström,Peter[JournalofMedicinalChemistry,1997,vol.40,#19,p.3091-3099]
[1]Stürzebecher,Jörg;Prasa,Dagmar;Hauptmann,Jörg;Vieweg,Helmut;Wikström,Peter[JournalofMedicinalChemistry,1997,vol.40,#19,p.3091-3099]
[1]Stürzebecher,Jörg;Prasa,Dagmar;Hauptmann,Jörg;Vieweg,Helmut;Wikström,Peter[JournalofMedicinalChemistry,1997,vol.40,#19,p.3091-3099]
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101